A new study published in Genome Research presents an interpretable artificial intelligence framework that improves both the accuracy and transparency of genomic prediction, a key challenge in fields ...
A new study published in Genome Research presents an interpretable artificial intelligence framework that improves both the ...
DENVER, April 07, 2026 (GLOBE NEWSWIRE) -- ( - For years, the conversation around next-generation technology has centered ...
Unlock the latest liquid biopsy market data. Explore growth drivers, precision oncology shifts, and the tech fueling ...
When a tiny lizard turned up at the edge of a proposed housing development outside Melbourne in 2023, it was the first ...
Discover how TP53 mutations in adult leukaemia impact treatment outcomes and potential strategies for improved patient care.
Vietnam Investment Review on MSN
TriNetX and Regeneron partner on 300 million patient health records
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 3, 2026 /PRNewswire/ -- TriNetX® and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a strategic collaboration to support Regeneron's ...
Regeneron has exclusive opportunity to connect large-scale genomic and proteomic data cohorts to TriNetX’s industry-leading global network of ...
Agentic AI in Healthcare Market OverviewThe global agentic AI in healthcare market is poised for exponential growth, with an ...
Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...
Regeneron collaborates with TriNetX to access de-identified HER of 300 million patients to drive research and product development in life sciences and digital health solutions: Ta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results